South San Francisco, CA · Founded 2018 · Privately Held (backing)
Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. Neuron23 is based in South San Francisco, CA and was founded in 2018. Its last reported valuation was $272 million in Jun 2025. It has raised $310 million.
Last reported valuation
$271.5M
Oct 2026
Priced at
—
Total raised
$310.0M
Last round
—
Cap table — not yet on record
Neuron23's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Neuron23 with a free account
·The complete investor list: 14 names
·Watch Neuron23: the Monday email on marks, rounds and moves
